Ladirubicin is an anthracyclines analogue, and the leading compound of alkylcyclines. References: Soares PI, Dias SJ, Novo CM, Ferreira IM, Borges JP. Doxorubicin vs. ladirubicin: methods for improving osteosarcoma treatment. Mini Rev Med Chem. 2012 Oct;12(12):1239-49. PubMed PMID: 22512558.
纯度:≥98%
CAS:171047-47-5